Novel diarylsulfonylurea derivatives as potent antimitotic agents. 2004

Semi Kim, and Ji Hyun Park, and Sun-Young Koo, and Jung In Kim, and Min-Hyeung Kim, and Ji Eun Kim, and Kiwon Jo, and Hwan Geun Choi, and Sung Bae Lee, and Sang-Hun Jung
LG Life Sciences, Ltd/R&D Park, 104-1 Moonji-dong, Yuseong-gu, Daejon 305-380, South Korea. semikim@lgls.co.kr

A novel series of diarylsulfonylurea derivatives were synthesized and evaluated for interaction with tubulin and for cytotoxicity against human cancer cell lines. These derivatives demonstrated good inhibitory activity against tubulin polymerization, which was well correlated with promising antiproliferative activity as well as G2/M phase cell cycle arrest. Furthermore, several compounds were also efficacious against multidrug-resistant cancer cells, which are resistant to many other known microtubule inhibitors.

UI MeSH Term Description Entries
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013453 Sulfonylurea Compounds A class of compounds in which a sulfone functional group is attached to UREA. Compounds, Sulfonylurea
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D050257 Tubulin Modulators Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. Microtubule Modulator,Tubulin Inhibitor,Tubulin Modulator,Tubulin Polymerization Inhibitor,Tubulin Polymerization Promoter,Tubulin Promoter,Microtubule Modulators,Tubulin Inhibitors,Tubulin Polymerization Inhibitors,Tubulin Polymerization Promoters,Tubulin Promoters,Inhibitor, Tubulin,Inhibitor, Tubulin Polymerization,Inhibitors, Tubulin,Inhibitors, Tubulin Polymerization,Modulator, Microtubule,Modulator, Tubulin,Modulators, Microtubule,Modulators, Tubulin,Polymerization Inhibitor, Tubulin,Polymerization Inhibitors, Tubulin,Polymerization Promoter, Tubulin,Polymerization Promoters, Tubulin,Promoter, Tubulin,Promoter, Tubulin Polymerization,Promoters, Tubulin,Promoters, Tubulin Polymerization

Related Publications

Semi Kim, and Ji Hyun Park, and Sun-Young Koo, and Jung In Kim, and Min-Hyeung Kim, and Ji Eun Kim, and Kiwon Jo, and Hwan Geun Choi, and Sung Bae Lee, and Sang-Hun Jung
February 2009, Bioorganic & medicinal chemistry,
Semi Kim, and Ji Hyun Park, and Sun-Young Koo, and Jung In Kim, and Min-Hyeung Kim, and Ji Eun Kim, and Kiwon Jo, and Hwan Geun Choi, and Sung Bae Lee, and Sang-Hun Jung
July 2001, Bioorganic & medicinal chemistry letters,
Semi Kim, and Ji Hyun Park, and Sun-Young Koo, and Jung In Kim, and Min-Hyeung Kim, and Ji Eun Kim, and Kiwon Jo, and Hwan Geun Choi, and Sung Bae Lee, and Sang-Hun Jung
October 2006, Journal of medicinal chemistry,
Semi Kim, and Ji Hyun Park, and Sun-Young Koo, and Jung In Kim, and Min-Hyeung Kim, and Ji Eun Kim, and Kiwon Jo, and Hwan Geun Choi, and Sung Bae Lee, and Sang-Hun Jung
May 2010, Journal of medicinal chemistry,
Semi Kim, and Ji Hyun Park, and Sun-Young Koo, and Jung In Kim, and Min-Hyeung Kim, and Ji Eun Kim, and Kiwon Jo, and Hwan Geun Choi, and Sung Bae Lee, and Sang-Hun Jung
January 2018, Current medicinal chemistry,
Semi Kim, and Ji Hyun Park, and Sun-Young Koo, and Jung In Kim, and Min-Hyeung Kim, and Ji Eun Kim, and Kiwon Jo, and Hwan Geun Choi, and Sung Bae Lee, and Sang-Hun Jung
December 2001, Journal of medicinal chemistry,
Semi Kim, and Ji Hyun Park, and Sun-Young Koo, and Jung In Kim, and Min-Hyeung Kim, and Ji Eun Kim, and Kiwon Jo, and Hwan Geun Choi, and Sung Bae Lee, and Sang-Hun Jung
April 2001, Bioorganic & medicinal chemistry letters,
Semi Kim, and Ji Hyun Park, and Sun-Young Koo, and Jung In Kim, and Min-Hyeung Kim, and Ji Eun Kim, and Kiwon Jo, and Hwan Geun Choi, and Sung Bae Lee, and Sang-Hun Jung
June 2022, Molecules (Basel, Switzerland),
Semi Kim, and Ji Hyun Park, and Sun-Young Koo, and Jung In Kim, and Min-Hyeung Kim, and Ji Eun Kim, and Kiwon Jo, and Hwan Geun Choi, and Sung Bae Lee, and Sang-Hun Jung
September 2021, Bioorganic chemistry,
Semi Kim, and Ji Hyun Park, and Sun-Young Koo, and Jung In Kim, and Min-Hyeung Kim, and Ji Eun Kim, and Kiwon Jo, and Hwan Geun Choi, and Sung Bae Lee, and Sang-Hun Jung
May 2010, European journal of medicinal chemistry,
Copied contents to your clipboard!